Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study

BACKGROUND: Improvement in treatment for patients with recurrent ovarian cancer is needed. Standard therapy in patients with platinum-sensitive recurrent ovarian cancer consists of platinum-based chemotherapy. Median overall survival is reported between 18 and 35 months. Currently, the role of surge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van de Laar, Rafli, Zusterzeel, Petra LM, Van Gorp, Toon, Buist, Marrije R, van Driel, Willemien J, Gaarenstroom, Katja N, Arts, Henriette JG, van Huisseling, Johannes CM, Hermans, Ralph HM, Pijnenborg, Johanna MA, Schutter, Eltjo MJ, Pelikan, Harold MP, Vollebergh, Jos HA, Engelen, Mirjam JA, IntHout, Joanna, Kruitwagen, Roy FPM, Massuger, Leon FAG
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3897943/
https://ncbi.nlm.nih.gov/pubmed/24422892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-22
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados